This inventor holds 1 USPTO granted patent. Top assignees: Bristol-Myers Squibb Compnay, Pfizer Corporation. Active years: 2017.
Company Filing History:
1 out of 3,735 
1 out of 4,486 
Years Active: 2017
Title: Michelle Madar: Innovator in Antibody Development
Introduction
Michelle Madar is an accomplished inventor based in Arlington, MA (US). She has made significant contributions to the field of biotechnology, particularly in the development of antibodies for therapeutic applications. Her work focuses on addressing diseases and conditions mediated by tumor necrosis factor-like ligand 1A (TL1A).
Latest Patents
Michelle holds a patent for "Tumor necrosis factor-like ligand 1A specific antibodies and compositions and uses thereof." This invention provides antibodies, or antigen-binding fragments thereof, which specifically bind to TL1A. The patent also outlines methods for obtaining such antibodies and nucleic acids encoding them. Furthermore, it relates to compositions and therapeutic methods for using these antibodies in the treatment and prevention of TL1A-mediated diseases, disorders, or conditions.
Career Highlights
Throughout her career, Michelle has worked with prominent companies in the pharmaceutical industry, including Pfizer Corporation and Bristol-Myers Squibb Company. Her experience in these organizations has allowed her to contribute to groundbreaking research and development in the field of therapeutics.
Collaborations
Michelle has collaborated with notable professionals in her field, including Peter Brams and Brigitte Devaux. These partnerships have enhanced her research and expanded the impact of her innovations.
Conclusion
Michelle Madar is a pioneering inventor whose work in antibody development has the potential to transform therapeutic approaches for various diseases. Her contributions to biotechnology continue to make a significant impact in the medical field.